Acquired resistance to GDC-0941 in SUM-159 breast cancer cells was found to be associated with a focal amplification in the MYC locus and inhibition of BET with JQ1 sensitized resistant cells to GDC-0941 treatment49. This evidence concerns the gene MYC and breast cancer.